Study of Post-anesthesia Management in Patients Undergoing Neurosurgery
Launched by BEIJING TIANTAN HOSPITAL · Apr 22, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better manage patients after they have neurosurgery, which is surgery on the brain or nervous system. The researchers want to find out what factors might lead to complications after surgery so they can help prevent these complications and improve patient outcomes. By identifying issues early, they hope to reduce the risks of serious problems and save lives.
If you or a loved one has had neurosurgery at Beijing Tiantan Hospital, you might be eligible to participate in this study. To join, participants must not have severe cognitive problems before the surgery and must agree to be part of the study by signing an informed consent form. Those who take part will help researchers learn more about how to improve care after neurosurgery, which could lead to better recovery experiences for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients received neurosurgery in Beijing Tiantan hospital.
- Exclusion Criteria:
- • Preoperative severe cognitive dysfunction ；
- • Refused to sign informed consent.
About Beijing Tiantan Hospital
Beijing Tiantan Hospital, affiliated with Capital Medical University, is a leading medical institution in China renowned for its expertise in neurology, neurosurgery, and various other specialties. As a prominent clinical trial sponsor, the hospital is committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on high-quality clinical trials, Beijing Tiantan Hospital adheres to rigorous ethical standards and regulatory requirements, fostering collaboration with academic institutions and industry partners to facilitate the development of cutting-edge therapies and interventions. Its state-of-the-art facilities and experienced research team enable the hospital to play a pivotal role in the global medical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Patients applied
Trial Officials
Yuming Peng, M.D., Ph.D
Study Chair
Department of Anesthesiology, Beijing Tiantan Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials